BioSpace News Archive

ICS-CERT has Issued an Advisory about a Medium Severity Vulnerability found in GE Aestiva and Aespire Devices

Blue Water Vaccines, a company developing a universal flu vaccine based on technology developed at the University of Oxford, has closed a $7 million seed capital round led by CincyTech.

New analyses from Phase III HAVEN studies support Hemlibra’s sustained efficacy, safety and quality of life benefit in people with hemophilia A, with and without factor VIII inhibitors

India-based Accutest Biologics Private Limited, a leading CRO for high-quality Biochemical characterization and Bioanalytical services supporting preclinical and clinical development of Biologics and Biosimilars, has received the prestigious OECD-Good Laboratory Practice certification.

Fully human, potentially first-in-class, monoclonal antibody designed to target a fundamental immunosuppressive mechanism in hard-to-treat cancers

Argon Medical Devices, Inc., a leading global manufacturer of specialty medical devices used in interventional procedures, announced that it has entered into a definitive license agreement with Hatch Medical, L.L.C. for exclusive global rights to market and distribute the Scorpion™ TIPS Access Systems.

One of the largest private EU biotech funding events expands global shareholder base

Cell BT, Inc. (CBI), an immuno-therapy company focused on the discovery and development of innovative cancer therapeutics based on next generation CAR-T antibody constructs directed to novel biological targets, today announced that Joshua J. Ofman, M.D., MSHS, has been appointed to the CBI Board of Directors.

Blood donations are being distributed to hospitals faster than donations are coming in; blood donors needed to help avoid delays in lifesaving medical care

Dr. Reddy’s Laboratories Ltd. announced the launch of an over-the-counter (OTC) store-brand equivalent of Mucinex® D Extended Release Tablets in two strengths—Guaifenesin 600 mg and Pseudoephedrine HCl 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCl 120 mg—in the United States market, as approved by the U.S. Food and Drug Administration.